Differential expression of TKS4 isoforms and their role in cellular processes in breast cancer

Serhii Kropyvko1, Nazar Shevchuk1, Olga Gubar1

  • 1Department of Functional Genomics Institute of Molecular Biology and Genetics NAS of Ukraine Kyiv Ukraine.

Insights

The scaffold protein TKS4, crucial in cancer, has two isoforms, TKS4L and TKS4b, with distinct functions. Both promote cancer progression by driving epithelial-mesenchymal transition, suggesting TKS4 as a therapeutic target.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell biology

Background:

  • The scaffold protein TKS4 is implicated in cancer development.
  • Alternative splicing of the TKS4 gene produces TKS4L and TKS4b isoforms.
  • The distinct expression and functions of TKS4 isoforms are not well understood.

Purpose of the Study:

  • To investigate the differential expression and functional roles of TKS4L and TKS4b isoforms in breast cancer.
  • To identify binding partners and signaling interactions of TKS4 isoforms.
  • To explore the impact of TKS4 isoforms on cancer cell behavior.

Main Methods:

  • Differential expression analysis of TKS4 isoforms in cell lines and breast cancer tissues.
  • Identification of TKS4 isoform binding partners using biochemical assays.
  • Analysis of TKS4 isoform localization and tyrosine phosphorylation.
  • Assessment of TKS4 isoform effects on cell migration and epithelial-mesenchymal transition.

Main Results:

  • TKS4 isoforms show differential expression in breast cancer cells and tumors.
  • TKS4L binds to novel SRC homology 3-domain-containing partners, distinct from TKS4b.
  • TKS4b localizes to the nucleus, while TKS4L is primarily in the cytosol.
  • Both isoforms promote epithelial-mesenchymal transition and TKS4b enhances cell migration.

Conclusions:

  • TKS4L and TKS4b possess distinct cellular localizations and binding interactions, indicating functional divergence.
  • Both TKS4 isoforms contribute to breast cancer progression through oncogenic properties.
  • TKS4 isoforms represent potential therapeutic targets for breast cancer intervention.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...